• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  Fulcrum Announces Launch of Phase 2b Trial of Losmapimod for FSHD

  Posted by MD forums Moderator on August 28, 2019 at 11:41 am

  

  Fulcrum Therapeutics has announced the launch of a Phase 2b trial of losmapimod for facioscapulohumeral muscular dystrophy (FSHD) patients. Click here to read more about it.

  What do you think of this news?

  replied 4 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply